Inducible ventricular flutter and fibrillation predict for arrhythmia occurrence in coronary artery disease patients presenting with syncope of unknown origin

Journal of Cardiovascular Electrophysiology

Volumn 13, Issue 11, 2002, Pages 1103-1108

  Link, Mark S ^a,b   Saeed, Mohammad ^a   Gupta, Neera ^a   Homoud, Munther K ^a   Wang, Paul J ^a   Estes III, N A Mark ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Electrophysiologic study; Sustained monomorphic ventricular tachycardia; Syncope; Ventricular fibrillation; Ventricular flutter

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVERSION; CORONARY ARTERY DISEASE; DEFIBRILLATOR; ELECTROPHYSIOLOGY; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART CATHETERIZATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE FLUTTER; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SYNCOPE;

EID: 0036853217     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2002.01103.x     Document Type: Article

References (37)

1. Kapoor WN: An overview of the evaluation and management of syncope. In Grubb BP, Olshansky B, eds: Syncope: Mechanism and Management. Futura Publishing Co., Armonk, NY, 1998, pp. 1-13.
2. Day SC, Cook EF, Funkenstein H, Goldman L: Evaluation and outcome of emergency room patients with transient loss of consciousness. Am J Med 1982;73:15-23.
3. Manolis AS, Linzer M, Salem D, Estes III NAM: Syncope: Current diagnostic evaluation and management. Ann Intern Med 1990;112:850-863.
4. Kapoor WN: Workup and management of patients with syncope. Med Clin North Am 1995;79:1153-1170.
5. Gregoratos G, Cheitlin MD, Conill A, Epstein AE, Fellows C, Ferguson TB, Freedman RA, Hlatky MA, Naccarelli GV, Saksena S, Schlant RC, Silka MJ: ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmic devices. J Am Coll Cardiol 1998;31:1175-1209.
6. Link MS, Costeas XF, Griffith JL, Colburn CD, Estes NAM III, Wang PJ: High incidence of appropriate implantable cardioverter-defibrillator therapy in patients with syncope of unknown etiology and inducible ventricular arrhythmias. J Am Coll Cardiol 1997;29:370-375.
7. Militianu A, Salacata A, Seibert K, Kehoe R, Baga JJ, Meissner MD, Pires LA, Schuger CD, Steinman RT, Mosteller RD, Palti A J, Ben David J, Lessmeier TJ, Lehmann MH: Implantable cardioverter-defibrillator utilization among device recipients presenting exclusively with syncope or near-syncope. J Cardiovasc Electrophysiol 1997;8:1087-1097.
8. Mittal S, Iwai S, Stein KM, Markowitz SM, Slotwiner DJ, Lerman BB: Long-term outcome of patients with unexplained syncope treated with an electrophysiologic-guided approach in the implantable cardioverter-defibrillator era. J Am Coll Cardiol 1999;34:1082-1089.
9. Andrews NP, Fogel RI, Pelargonio G, Evans JJ, Prystowsky EN: Implantable defibrillator event rates in patients with unexplained syncope and inducible ventricular arrhythmias. J Am Coll Cardiol 1999;34:2023-2030.
10. Telfer EA, Olshansky B: Use of electrophysiological studies in syncope: Practical aspects for diagnosis and treatment. In Grubb BP, Olshansky B, eds: Syncope: Mechanisms and Management. Futura Publishing Co., Armonk, NY, 1998, pp. 179-221.
11. Olshansky B: Syncope: Overview and approach to management. In Olshansky B, ed: Syncope: Mechanisms and Management. Futura Publishing Co., Armonk, NY, 1998, pp. 15-71.
12. Calkins H: Syncope. In Zipes DP, Jalife J, eds: Cardiac Electrophysiology: From Cell to Bedside. WB Saunders Company, Philadelphia, 2000, pp. 873-881.
13. Bachinsky WB, Linzer M, Weld L, Estes NAM: Usefulness of clinical characteristics in predicting the outcome of electrophysiologic studies in unexplained syncope. Am J Cardiol 1992;69:1044-1049.
14. Morady F, DiCarlo LA, Baerman JM, de Buitleir M: Comparison of coupling intervals that induce clinical and nonclinical forms of ventricular tachycardia during programmed stimulation. Am J Cardiol 1986;57:1269-1273.
15. MADIT Executive Committee: Multicenter Automatic Defibrillator Implantation Trial (MADIT): Design and clinical protocol. Pacing Clin Electrophysiol 1991;14:920-927.
16. Garan H, McGovern B: Electrophysiology testing and cardiac mapping. In Podrid PJ, Kowey PR, eds: Cardiac Arrhythmia: Mechanisms, Diagnosis, and Management. Lippincott Williams & Wilkins, New York, 2001, pp. 231-262.
17. Wellens HJ, Brugada P, Stevenson WG: Programmed electrical stimulation of the heart in patients with life-threatening ventricular arrhythmias: What is the significance of induced arrhythmias and what is the correct stimulation protocol? Circulation 1985;72:1-7.
18. Benditt DG, Benson DW, Klein GJ, Pritzker MR, Kriett JM, Anderson RW: Prevention of recurrent sudden cardiac arrest: Role of provocative electropharmacologic testing. J Am Coll Cardiol 1983;2:418-425.
19. Saxon LA, Uretz EF, Denes P: Significance of the clinical presentation in ventricular tachycardia/fibrillation. Am Heart J 1989;118:695-701.
20. Josephson ME: Recurrent ventricular tachycardia. In: Clinical Cardiac Electrophysiology. Lea & Febiger, Philadelphia, 1993, pp. 482-489.
21. Ruskin JN, DiMarco JP, Garan H: Out of hospital cardiac arrest. Electrophysiologic observations and selection of long term antiarrhythmics. N Engl J Med 1980;303:607-613.
22. Wilber DJ, Garan H, Finkelstein D, Kelly E, Newell J, McGovern B, Ruskin JN: Out-of-hospital arrest: Use of electrophysiologic testing in the prediction of long-term outcome. N Engl J Med 1988;318:19-24.
23. Camm AJ, Katritsis DG: Risk stratification of patients with ventricular arrhythmias. In Zipes DP, Jalife J, eds: Cardiac Electrophysiology: From Cell to Bedside. WB Saunders Company, Philadelphia, 2000, pp. 808-828.
24. Brugada P, Green M, Abdollah H, Wellens HJJ: Significance of ventricular arrhythmias initiated by programmed ventricular stimulation: The importance of the type of ventricular arrhythmia induced and the number of premature stimuli required. Circulation 1984;69:87-92.
25. Stevenson WG, Brugada P, Waldecker B, Zehender M, Wellens HJJ: Can potentially significant polymorphic ventricular arrhythmias initiated by programmed stimulation be distinguished from those that are nonspecific. Am Heart J 1986;111:1073-1080.
26. DiCarlo LA, Morady F, Schwartz AB, Shen EN, Baerman JM, Krol RB, Scheinman MM, Sung RJ: Clinical significance of ventricular fibrillation-flutter induced by ventricular programmed stimulation. Am Heart J 1985;109:959-963.
27. Denniss AR, Richards DA, Cody DV, Russell PA, Young AA, Cooper MJ, Ross DL, Uther JB: Prognostic significance of ventricular tachycardia and fibrillation induced at programmed stimulation and delayed potentials detected on the signal-averaged electrocardiograms of survivors of acute myocardial infarction. Circulation 1986;74:731-745.
28. Bourke JP, Richards DAB, Ross DL, McGuire MA, Uther JB: Does the induction of ventricular flutter or fibrillation at electrophysiologic testing after myocardial infarction have any prognostic significance? Am J Cardiol 1995;75:431-435.
29. Sager PT, Perlmutter RA, Rosenfeld LE, McPherson CA, Batsford WP: Rapid self-terminating ventricular tachycardia induced during electrophysiologic study: A prospective evaluation. J Am Coll Cardiol 1989;13:385-390.
30. Moss AJ, Hall J, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-1940.
31. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G: A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999;341:1882-1890.
32. Buxton AE, Lee KL, DiCarlo L, Gold MR, Greer GS, Prystowsky EN, O'Toole MF, Tang A, Fisher JD, Coromilas J, Talajic M, Hafley G: Electrophysiologic testing to identify patients with coronary disease who are at risk for sudden death. N Engl J Med 2000;342:1937-1945.
33. Mittal S, Hao SC, Iwai S, Stein KM, Markowitz SM, Slotwiner DJ, Lerman BB: Significance of inducible ventricular fibrillation in patients with coronary artery disease and unexplained syncope. J Am Coll Cardiol 2001;38:371-376.
34. Menon V, Steinberg JS, Akiyama T, Beckman K, Carillo L, Kutalek S: Implantable cardioverter defibrillator discharge rates in patients with unexplained syncope, structural heart disease, and inducible ventricular tachycardia at electrophysiologic study. Clin Cardiol 2000;23:195-200.
35. AVID Investigators: A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-1583.
36. Kuck K-H, Cappato R, Siebels J, Ruppel R: Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest. Circulation 2000;102:748-754.
37. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, Green MS, Klein G: Canadian Implantable Defibrillator Study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297-1302.